What they were paid
TScan Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $90,609 | $0 | $71,623 | $0 | $162,232 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TScan Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160304, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025TScan Therapeutics pays directors a $40,000 cash retainer and $71,623 in equity.
Committees
FY2025 · as the proxy prints themCompensation (Chair) · Research and Clinical Development
The rest of the TScan Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara Klencke, M.D | Independent Director | $145,779 |
| Gabriela Gruia, M.D | Independent Director | $129,122 |
| Garry Nicholson | Independent Director | $125,363 |
| Gavin MacBeath, Ph.D | Director | $0 |
| Katina Dorton, J.D., M.B.A | Independent Director | $139,109 |
| R. Keith Woods | Independent Director | $125,265 |
The full TScan Therapeutics compensation record
free company briefThis page is one director within TScan Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat